<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2024-69-2-26-33</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1967</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Формирование когнитивных процессов у детей с аутизмом. Часть II. Генетические механизмы</article-title><trans-title-group xml:lang="en"><trans-title>Formation of cognitive processes in children with autism. Part II. Genetic mechanisms</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0091-2224</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глотов</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Glotov</surname><given-names>O. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глотов Олег Сергеевич - д.б.н., зав. отделом вирусологических и молекулярно-генетических методов диагностики Детского научно-клинического центра инфекционных болезней; ст. науч. сотр. отдела геномной медицины; вед. науч. сотр. лаборатории исследований тактильной коммуникации департамента научной деятельности</p><p>199034 Санкт-Петербург, Менделеевская линия, д. 3</p></bio><bio xml:lang="en"><p>Saint Petersburg</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2464-7370</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чернов Александр Николаевич - к.б.н., ст. науч. сотр. отдела общей патологии и патофизиологии; науч. сотр. отдела геномной медицины</p><p>197376 Санкт-Петербург, ул. акад. Павлова, д. 12</p></bio><bio xml:lang="en"><p>Saint Petersburg</p></bio><email xlink:type="simple">al.chernov@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Cучко</surname><given-names>П. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Suchko</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сучко Павел Александрович - студент IV курса кафедры молекулярной биотехнологии</p><p>190013 Санкт-Петербург, Московский проспект, д. 24–26/49 А</p></bio><bio xml:lang="en"><p>Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4828-8053</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эйсмонт</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Eismont</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Эйсмонт Юрий Александрович - к.б.н., ст. науч. сотр. научно-исследовательского отдела вирусологии и молекулярно-биологических методов исследования</p><p>197022 Санкт-Петербург, ул. профессора Попова, д. 9</p></bio><bio xml:lang="en"><p>Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5112-7878</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Майорова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mayorova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Майорова Лариса Алексеевна - к.м.н., ст. науч. сотр. лаборатории физиологии сенсорных систем; ст. науч. сотр.; зав. лабораторией экспериментальной неврологии и нейровизуализации</p><p>117485 Москва, ул. Бутлерова, д. 5 А</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства»; ФГБНУ «Научно-исследовательский институт акушерства, гинекологии и репродуктологии им. Д.О. Отта»; ФГБОУ ВО «Государственный институт русского языка им. А.С. Пушкина»<country>Россия</country></aff><aff xml:lang="en">Pediatric Research and Clinical Center for Infectious Diseases; Ott Research Institute of Obstetrics, Gynecology and Reproductology; Pushkin State Russian Language Institute<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБНУ «Научно-исследовательский институт акушерства, гинекологии и репродуктологии им. Д.О. Отта»; ФГБНУ «Институт экспериментальной медицины»<country>Россия</country></aff><aff xml:lang="en">Ott Research Institute of Obstetrics, Gynecology and Reproductology; Institute of Experimental Medicine<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ФГБОУ ВО «Санкт-Петербургский государственный технологический институт (технический университет)»<country>Россия</country></aff><aff xml:lang="en">St. Petersburg State Technological Institute (Technical University)<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">ФГБУ «Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства»<country>Россия</country></aff><aff xml:lang="en">Pediatric Research and Clinical Center for Infectious Diseases<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru">ФГБОУ ВО «Государственный институт русского языка им. А.С. Пушкина»; ФГБУН «Институт высшей нервной деятельности и нейрофизиологии РАН»; ФБГНУ «Федеральный научно-клинический центр реаниматологии и реабилитологии»<country>Россия</country></aff><aff xml:lang="en">Pediatric Research and Clinical Center for Infectious Diseases; Institute of Higher Nervous Activity and Neurophysiology; Federal Scientific and Clinical Center for Reanimatology and Rehabilitation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>08</day><month>05</month><year>2024</year></pub-date><volume>69</volume><issue>2</issue><fpage>26</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1967">https://www.ped-perinatology.ru/jour/article/view/1967</self-uri><abstract><p>Аутизм и расстройства аутистического спектра — нервно-психические заболевания, которые начинают проявляться у детей в возрасте до 3 лет. За последнее десятилетие число детей с расстройствами аутистического спектра увеличилось в 10 раз и продолжает расти, составляя 1–2% населения планеты. В настоящее время диагностика расстройств аутистического спектра основывается только на клинических и поведенческих тестах, а биологические и генетические маркеры, которые могли бы способствовать раннему выявлению этого расстройства, отсутствуют. Цель: на основе анализа современных данных литературы о симптомах, генетических этиологических факторах, ассоциированных с аутизмом, изучить возмож- ность использования генов в качестве диагностических биомаркеров у детей с расстройствами аутистического спектра. Анализ данных литературы свидетельствует, что в основе нарушений внимания, скорости обработки информации, рабочей памяти, обучения лежат генетические (патогенные варианты, SNP) изменения экспрессии многих генов: BDNF, CAPS2, CNTNAP2, GABRB3, FMR1, FOXP1, GTF2I, HSD11B2, MECP2, NF2, NGF, NR3C1, OXTR, PAK2, RELN, SLC6A4, UBE3A и др. Некоторые из этих генов (RELN) ассоциированы с тяжестью расстройств аутистического спектра.</p></abstract><trans-abstract xml:lang="en"><p>Autism and autism spectrum disorders are neuropsychiatric diseases that begin to appear in children under 3 years. Over the past decade, the number of children with autism spectrum disorders has increased more than in 10-fold and continues to grow, accounting for 1–2% of the world’s population. Currently, the diagnosis of autism spectrum disorders is based only on clinical and behavioral tests, and there are no biological and genetic markers that could contribute to the early detection of this disorder. The review, based on the analysis of modern literature data about symptoms, genetic etiological factors that associated with autism, examines the possibility of using genes as diagnostic biomarkers in children with autism spectrum disorders. Analysis of literature data shows that disorders of attention, speed of information processing, working memory, learning are based on genetic (mutations, SNPs) and epigenetic (methylation) changes in the expression of many genes: BDNF, CAPS2, CNTNAP2, GABRB3, FMR1, FOXP1, GTF2I, HSD11B2, MECP2, NF2, NGF, NR3C1, OXTR, PAK2, RELN, SLC6A4, UBE3A, etc. Some of these genes (RELN) are associated with ASD severity.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>аутизм</kwd><kwd>расстройства аутистического спектра</kwd><kwd>симптомы</kwd><kwd>этиологические факторы</kwd><kwd>гены</kwd><kwd>генетические ассоциации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>autism</kwd><kwd>autism spectrum disorders</kwd><kwd>symptoms</kwd><kwd>etiological factors</kwd><kwd>genes</kwd><kwd>genetic associations</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Jasoliya M., Gu J., AlOlaby R.R., Durbin-Johnson B., Chedin F., Tassone F. Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome. Genes (Basel) 2022; 13(10): 1795. DOI: 10.3390/genes13101795</mixed-citation><mixed-citation xml:lang="en">Jasoliya M., Gu J., AlOlaby R.R., Durbin-Johnson B., Chedin F., Tassone F. Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome. Genes (Basel) 2022; 13(10): 1795. DOI: 10.3390/genes13101795</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Autism spectrum disorders. World Health Organization. http://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders / Ссылка активна на 6.02.2024.</mixed-citation><mixed-citation xml:lang="en">Autism spectrum disorders. World Health Organization. http://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders / Ссылка активна на 6.02.2024.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Maenner M.J., Shaw K.A., Baio J. Prevalence of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 sites, united states, 2016. MMWR Surveill Summ 2020; 69: 1. DOI: 10.15585/mmwr.ss6802a1</mixed-citation><mixed-citation xml:lang="en">Maenner M.J., Shaw K.A., Baio J. Prevalence of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 sites, united states, 2016. MMWR Surveill Summ 2020; 69: 1. DOI: 10.15585/mmwr.ss6802a1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Living With Autism. https://www.easterseals.com/in-sw/explore-resources/living-with-autism / Ссылка активна на 03.10.2023.</mixed-citation><mixed-citation xml:lang="en">Living With Autism. https://www.easterseals.com/in-sw/explore-resources/living-with-autism / Ссылка активна на 03.10.2023.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cortese S., Solmi M., Michelini G., Bellato A., Blanner C., Canozzi A. et al. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: A systematic review. World Psychiatry 2023; 22: 129–149. DOI: 10.1002/wps.21037</mixed-citation><mixed-citation xml:lang="en">Cortese S., Solmi M., Michelini G., Bellato A., Blanner C., Canozzi A. et al. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: A systematic review. World Psychiatry 2023; 22: 129–149. DOI: 10.1002/wps.21037</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Doernberg E., Hollander E. Neurodevelopmental disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11. CNS Spectrums 2016; 21(4): 295–299. DOI: 10.1017/S1092852916000262</mixed-citation><mixed-citation xml:lang="en">Doernberg E., Hollander E. Neurodevelopmental disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11. CNS Spectrums 2016; 21(4): 295–299. DOI: 10.1017/S1092852916000262</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Treffert D.A. The savant syndrome: an extraordinary condition. A synopsis: past, present, future. Philosophical Transactions of The Royal Society B. Biol Scie 2009; 364(1522): 1351–1357. DOI: 10.1098/rstb.2008.0326</mixed-citation><mixed-citation xml:lang="en">Treffert D.A. The savant syndrome: an extraordinary condition. A synopsis: past, present, future. Philosophical Transactions of The Royal Society B. Biol Scie 2009; 364(1522): 1351–1357. DOI: 10.1098/rstb.2008.0326</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lai M.C., Lombardo M.V., Baron-Cohen S. Autism. Lancet 2014; 383(9920): 896–910. DOI: 10.1016/S0140–6736(13)61539–1</mixed-citation><mixed-citation xml:lang="en">Lai M.C., Lombardo M.V., Baron-Cohen S. Autism. Lancet 2014; 383(9920): 896–910. DOI: 10.1016/S0140–6736(13)61539–1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kaufmann W.E., Kidd S. A., Andrews H.F., Budimirovic D.B., Esler A., Haas-Givler B. et al. Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. Pediatrics 2017; 139(Suppl 3): S194–S206. DOI: 10.1542/peds.2016–1159F</mixed-citation><mixed-citation xml:lang="en">Kaufmann W.E., Kidd S. A., Andrews H.F., Budimirovic D.B., Esler A., Haas-Givler B. et al. Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. Pediatrics 2017; 139(Suppl 3): S194–S206. DOI: 10.1542/peds.2016–1159F</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Buiting K., Williams C., Horsthemke B. Angelman syndrome — insights into a rare neurogenetic disorder. Nat Rev Neurol 2016; 12(10): 584–593. DOI: 10.1038/nrneurol.2016.133</mixed-citation><mixed-citation xml:lang="en">Buiting K., Williams C., Horsthemke B. Angelman syndrome — insights into a rare neurogenetic disorder. Nat Rev Neurol 2016; 12(10): 584–593. DOI: 10.1038/nrneurol.2016.133</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Horigane S.-I., Ozawa Y., Zhang J., Todoroki H., Miao P., Haijima A. et al. A mouse model of Timothy syndrome exhibits altered social competitive dominance and inhibitory neuron development. FEBS Open Bio 2020; 10(8): 1436–1446. DOI: 10.1002/2211–5463.12924</mixed-citation><mixed-citation xml:lang="en">Horigane S.-I., Ozawa Y., Zhang J., Todoroki H., Miao P., Haijima A. et al. A mouse model of Timothy syndrome exhibits altered social competitive dominance and inhibitory neuron development. FEBS Open Bio 2020; 10(8): 1436–1446. DOI: 10.1002/2211–5463.12924</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Spinazzi N.A., Velasco A.B., Wodecki D.J., Patel L. Autism Spectrum Disorder in Down Syndrome: Experiences from Caregivers. J Autism Dev Disord 2023. DOI: 10.1007/s10803–022–05758-x</mixed-citation><mixed-citation xml:lang="en">Spinazzi N.A., Velasco A.B., Wodecki D.J., Patel L. Autism Spectrum Disorder in Down Syndrome: Experiences from Caregivers. J Autism Dev Disord 2023. DOI: 10.1007/s10803–022–05758-x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Quesnel-Vallières M., Weatheritt R.J., Cordes S.P., Blencowe B.J. Autism Spectrum Disorder: Insights into Convergent Mechanisms from Transcriptomics. Nat Rev Genet 2019; 20: 51–63. DOI: 10.1038/s41576–018–0066–2</mixed-citation><mixed-citation xml:lang="en">Quesnel-Vallières M., Weatheritt R.J., Cordes S.P., Blencowe B.J. Autism Spectrum Disorder: Insights into Convergent Mechanisms from Transcriptomics. Nat Rev Genet 2019; 20: 51–63. DOI: 10.1038/s41576–018–0066–2</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dickerson A.S., Rahbar M.H., Bakian A.V., Bilder D.A., Harrington R.A., Pettygrove S. et al. Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Environment Monitoring Assessm 2016; 188(7): 407. DOI: 10.1007/s10661–016–5405–1</mixed-citation><mixed-citation xml:lang="en">Dickerson A.S., Rahbar M.H., Bakian A.V., Bilder D.A., Harrington R.A., Pettygrove S. et al. Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Environment Monitoring Assessm 2016; 188(7): 407. DOI: 10.1007/s10661–016–5405–1</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bölte S., Girdler S., Marschik P.B. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci 2019; 76: 1275–1297. DOI: 10.1007/s00018–018–2988–4</mixed-citation><mixed-citation xml:lang="en">Bölte S., Girdler S., Marschik P.B. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci 2019; 76: 1275–1297. DOI: 10.1007/s00018–018–2988–4</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Emberti Gialloreti L., Mazzone L., Benvenuto A., Fasano A., Alcon A.G., Kraneveld A. et al. Risk and protective environmental factors associated with autism spectrum disorder: evidence-based principles and recommendations. J Clin Med 2019; 8(2): 217. DOI: 10.3390/jcm8020217</mixed-citation><mixed-citation xml:lang="en">Emberti Gialloreti L., Mazzone L., Benvenuto A., Fasano A., Alcon A.G., Kraneveld A. et al. Risk and protective environmental factors associated with autism spectrum disorder: evidence-based principles and recommendations. J Clin Med 2019; 8(2): 217. DOI: 10.3390/jcm8020217</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cheroni C., Caporale N., Testa G. Autism spectrum disorder at the crossroad between genes and environment: Contributions; convergences; and interactions in ASD developmental pathophysiology. Mol Autism 2020; 11: 69. DOI: 10.1186/s13229–020–00370–1</mixed-citation><mixed-citation xml:lang="en">Cheroni C., Caporale N., Testa G. Autism spectrum disorder at the crossroad between genes and environment: Contributions; convergences; and interactions in ASD developmental pathophysiology. Mol Autism 2020; 11: 69. DOI: 10.1186/s13229–020–00370–1</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Falk A., Heine V.M., Harwood A.J., Sullivan P.F., Peitz M., Brüstle O. et al. Modeling psychiatric disorders: from genomic findings to cellular phenotypes. Mol Psychiatry 2016; 21(9): 1167–1179. DOI: 10.1038/mp.2016.89</mixed-citation><mixed-citation xml:lang="en">Falk A., Heine V.M., Harwood A.J., Sullivan P.F., Peitz M., Brüstle O. et al. Modeling psychiatric disorders: from genomic findings to cellular phenotypes. Mol Psychiatry 2016; 21(9): 1167–1179. DOI: 10.1038/mp.2016.89</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">De Rubeis S., He X., Goldberg A.P., Poultney C.S., Samocha K., Cicek A.E. et al. Synaptic, Transcriptional and Chromatin Genes Disrupted in Autism. Nature 2014; 515: 209–215. DOI: 10.1038/nature13772</mixed-citation><mixed-citation xml:lang="en">De Rubeis S., He X., Goldberg A.P., Poultney C.S., Samocha K., Cicek A.E. et al. Synaptic, Transcriptional and Chromatin Genes Disrupted in Autism. Nature 2014; 515: 209–215. DOI: 10.1038/nature13772</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gaugler T., Klei L., Sanders S.J., Bodea C.A., Goldberg A.P., Lee A.B. et al. Most Genetic Risk for Autism Resides with Common Variation. Nat Genet 2014; 46: 881–885. DOI: 10.1038/ng.3039</mixed-citation><mixed-citation xml:lang="en">Gaugler T., Klei L., Sanders S.J., Bodea C.A., Goldberg A.P., Lee A.B. et al. Most Genetic Risk for Autism Resides with Common Variation. Nat Genet 2014; 46: 881–885. DOI: 10.1038/ng.3039</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sanders S.J., He X., Willsey A.J., Ercan-Sencicek A.G., Samocha K.E., Cicek A.E. et al. Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Neuron 2015; 87: 1215–1233. DOI: 10.1016/j.neuron.2015.09.016</mixed-citation><mixed-citation xml:lang="en">Sanders S.J., He X., Willsey A.J., Ercan-Sencicek A.G., Samocha K.E., Cicek A.E. et al. Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Neuron 2015; 87: 1215–1233. DOI: 10.1016/j.neuron.2015.09.016</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Yu T.W., Chahrour M.H., Coulter M.E., Jiralerspong S., Okamura-Ikeda K., Ataman B. et al. Using Whole-Exome Sequencing to Identify Inherited Causes of Autism. Neuron 2013; 77: 259–273. DOI: 10.1016/j.neuron.2012.11.002</mixed-citation><mixed-citation xml:lang="en">Yu T.W., Chahrour M.H., Coulter M.E., Jiralerspong S., Okamura-Ikeda K., Ataman B. et al. Using Whole-Exome Sequencing to Identify Inherited Causes of Autism. Neuron 2013; 77: 259–273. DOI: 10.1016/j.neuron.2012.11.002</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Doan R.N., Lim E.T., De Rubeis S., Betancur C., Cutler D.J., Chiocchetti A.G., et al.; Autism Sequencing Consortium. Recessive Gene Disruptions in Autism Spectrum Disorder. Nat Genet 2019; 51: 1092–1098. DOI: 10.1038/s41588–019–0433–8</mixed-citation><mixed-citation xml:lang="en">Doan R.N., Lim E.T., De Rubeis S., Betancur C., Cutler D.J., Chiocchetti A.G., et al.; Autism Sequencing Consortium. Recessive Gene Disruptions in Autism Spectrum Disorder. Nat Genet 2019; 51: 1092–1098. DOI: 10.1038/s41588–019–0433–8</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yang C., Li J., Wu Q., Yang X., Huang A.Y., Zhang J. et al. AutismKB 2.0: A knowledgebase for the genetic evidence of autism spectrum disorder. Database 2018; 2018: bay106. DOI: 10.1093/database/bay106</mixed-citation><mixed-citation xml:lang="en">Yang C., Li J., Wu Q., Yang X., Huang A.Y., Zhang J. et al. AutismKB 2.0: A knowledgebase for the genetic evidence of autism spectrum disorder. Database 2018; 2018: bay106. DOI: 10.1093/database/bay106</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Weiner D.J., Wigdor E.M., Ripke S., Walters R.K., Kosmicki J.A., Grove J., et al.; iPSYCH-Broad Autism Group. Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nat Genet 2017; 49(7): 978–985. DOI: 10.1038/ng.3863</mixed-citation><mixed-citation xml:lang="en">Weiner D.J., Wigdor E.M., Ripke S., Walters R.K., Kosmicki J.A., Grove J., et al.; iPSYCH-Broad Autism Group. Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nat Genet 2017; 49(7): 978–985. DOI: 10.1038/ng.3863</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lord C., Brugha T.S., Charman T., Cusack J., Dumas G., Frazier T. et al. Autism spectrum disorder. Nat Rev Dis Prim 2020; 6: 5. DOI: 10.1038/s41572–019–0138–4</mixed-citation><mixed-citation xml:lang="en">Lord C., Brugha T.S., Charman T., Cusack J., Dumas G., Frazier T. et al. Autism spectrum disorder. Nat Rev Dis Prim 2020; 6: 5. DOI: 10.1038/s41572–019–0138–4</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lozano R., Gbekie C., Siper P.M., Srivastava S., Saland J.M., Sethuram S. et al. FOXP1 Syndrome: A Review of the Literature and Practice Parameters for Medical Assessment and Monitoring. J Neurodev Disord 2021; 13(1): 18. DOI: 10.1186/s11689–021–09358–1</mixed-citation><mixed-citation xml:lang="en">Lozano R., Gbekie C., Siper P.M., Srivastava S., Saland J.M., Sethuram S. et al. FOXP1 Syndrome: A Review of the Literature and Practice Parameters for Medical Assessment and Monitoring. J Neurodev Disord 2021; 13(1): 18. DOI: 10.1186/s11689–021–09358–1</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lavado A., He Y., Paré J., Neale G., Olson E.N., Giovannini M., Cao X. Tumor Suppressor Nf2 Limits Expansion of the Neural Progenitor Pool by Inhibiting Yap/Taz Transcriptional Coactivators. Development 2013; 140: 3323–3334. DOI: 10.1242/dev.096537</mixed-citation><mixed-citation xml:lang="en">Lavado A., He Y., Paré J., Neale G., Olson E.N., Giovannini M., Cao X. Tumor Suppressor Nf2 Limits Expansion of the Neural Progenitor Pool by Inhibiting Yap/Taz Transcriptional Coactivators. Development 2013; 140: 3323–3334. DOI: 10.1242/dev.096537</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Antonell A., Del Campo M., Magano L.F., Kaufmann L., de la Iglesia J.M., Gallastegui F. et al. Partial 7q11.23 Deletions Further Implicate GTF2I and GTF2IRD1 as the Main Genes Responsible for the Williams-Beuren Syndrome Neurocognitive Profile. J Med Genet 2010; 47(5): 312–320. DOI: 10.1136/jmg.2009.071712</mixed-citation><mixed-citation xml:lang="en">Antonell A., Del Campo M., Magano L.F., Kaufmann L., de la Iglesia J.M., Gallastegui F. et al. Partial 7q11.23 Deletions Further Implicate GTF2I and GTF2IRD1 as the Main Genes Responsible for the Williams-Beuren Syndrome Neurocognitive Profile. J Med Genet 2010; 47(5): 312–320. DOI: 10.1136/jmg.2009.071712</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Zeng C., Li J., Zhou Z., Ju X., Xia S. et al. PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior. Cell Rep 2018; 24: 2029–2041. DOI: 10.1016/j.celrep.2018.07.061</mixed-citation><mixed-citation xml:lang="en">Wang Y., Zeng C., Li J., Zhou Z., Ju X., Xia S. et al. PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior. Cell Rep 2018; 24: 2029–2041. DOI: 10.1016/j.celrep.2018.07.061</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Noroozi R., Taheri M., Ghafouri-Fard S., Bidel Z., Omrani M. D., Moghaddam A.S. et al. Meta-analysis of GABRB3 Gene Polymorphisms and Susceptibility to Autism Spectrum Disorder. J Mol Neurosci 2018; 65(4): 432–437. DOI: 10.1007/s12031–018–1114–2</mixed-citation><mixed-citation xml:lang="en">Noroozi R., Taheri M., Ghafouri-Fard S., Bidel Z., Omrani M. D., Moghaddam A.S. et al. Meta-analysis of GABRB3 Gene Polymorphisms and Susceptibility to Autism Spectrum Disorder. J Mol Neurosci 2018; 65(4): 432–437. DOI: 10.1007/s12031–018–1114–2</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Provenzi L., Fumagalli M., Sirgiovanni I., Giorda, R., Pozzoli U., Morandi F. et al. Pain-related stress during the Neonatal Intensive Care Unit stay and SLC6A4 methylation in very preterm infants. Front Behavioral Neuroscie 2015; 9: 99. DOI: 10.3389/fnbeh.2015.00099</mixed-citation><mixed-citation xml:lang="en">Provenzi L., Fumagalli M., Sirgiovanni I., Giorda, R., Pozzoli U., Morandi F. et al. Pain-related stress during the Neonatal Intensive Care Unit stay and SLC6A4 methylation in very preterm infants. Front Behavioral Neuroscie 2015; 9: 99. DOI: 10.3389/fnbeh.2015.00099</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kertes D.A., Kamin H.S., Hughes D.A., Rodney N.C., Bhatt S., Mulligan C.J. Prenatal Maternal Stress Predicts Methylation of Genes Regulating the Hypothalamic–Pituitary–Adrenocortical System in Mothers and Newborns in the Democratic Republic of Congo. Child Dev 2016; 87: 61–72. DOI: 10.1111/cdev.12487</mixed-citation><mixed-citation xml:lang="en">Kertes D.A., Kamin H.S., Hughes D.A., Rodney N.C., Bhatt S., Mulligan C.J. Prenatal Maternal Stress Predicts Methylation of Genes Regulating the Hypothalamic–Pituitary–Adrenocortical System in Mothers and Newborns in the Democratic Republic of Congo. Child Dev 2016; 87: 61–72. DOI: 10.1111/cdev.12487</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Jensen Peña C., Monk C., Champagne F.A. Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. PloS One 2012; 7(6): e39791. DOI: 10.1371/journal.pone.0039791</mixed-citation><mixed-citation xml:lang="en">Jensen Peña C., Monk C., Champagne F.A. Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. PloS One 2012; 7(6): e39791. DOI: 10.1371/journal.pone.0039791</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Pierzynowska K., Gaffke L., Żabińska M., Cyske Z., Rintz E., Wiśniewska K. et al. Roles of the Oxytocin Receptor (OXTR) in Human Diseases. Intern J Mol Sci 2023; 24(4): 3887. DOI: 10.3390/ijms24043887</mixed-citation><mixed-citation xml:lang="en">Pierzynowska K., Gaffke L., Żabińska M., Cyske Z., Rintz E., Wiśniewska K. et al. Roles of the Oxytocin Receptor (OXTR) in Human Diseases. Intern J Mol Sci 2023; 24(4): 3887. DOI: 10.3390/ijms24043887</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Song X., Zhou X., Yang F., Liang H., Wang Z., Li R. et al. Association between prenatal bisphenol a exposure and promoter hypermethylation of CAPS2, TNFRSF25, and HKR1 genes in cord blood. Environ Res 2020; 190: 109996. DOI: 10.1016/j.envres.2020.109996</mixed-citation><mixed-citation xml:lang="en">Song X., Zhou X., Yang F., Liang H., Wang Z., Li R. et al. Association between prenatal bisphenol a exposure and promoter hypermethylation of CAPS2, TNFRSF25, and HKR1 genes in cord blood. Environ Res 2020; 190: 109996. DOI: 10.1016/j.envres.2020.109996</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kundakovic M., Jaric I. The Epigenetic Link between Prenatal Adverse Environments and Neurodevelopmental Disorders. Genes (Basel) 2017; 8(3): 104. DOI: 10.3390/genes8030104</mixed-citation><mixed-citation xml:lang="en">Kundakovic M., Jaric I. The Epigenetic Link between Prenatal Adverse Environments and Neurodevelopmental Disorders. Genes (Basel) 2017; 8(3): 104. DOI: 10.3390/genes8030104</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Aloe L., Rocco M.L., Bianchi P., Manni L. Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med 2012; 10: 239. DOI: 10.1186/1479–5876–10–239</mixed-citation><mixed-citation xml:lang="en">Aloe L., Rocco M.L., Bianchi P., Manni L. Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med 2012; 10: 239. DOI: 10.1186/1479–5876–10–239</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Poot M. Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders. Mol Syndromol 2015; 6(1): 7–22. DOI: 10.1159/000371594</mixed-citation><mixed-citation xml:lang="en">Poot M. Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders. Mol Syndromol 2015; 6(1): 7–22. DOI: 10.1159/000371594</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Jossin Y. Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Development and Maturation. Biomolecules 2020; 10: 964. DOI: 10.3390/biom10060964</mixed-citation><mixed-citation xml:lang="en">Jossin Y. Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Development and Maturation. Biomolecules 2020; 10: 964. DOI: 10.3390/biom10060964</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Davis J.K., Broadie K. Multifarious Functions of the Fragile X Mental Retardation Protein. Trends Genet 2017; 33(10): 703–714. DOI: 10.1016/j.tig.2017.07.008</mixed-citation><mixed-citation xml:lang="en">Davis J.K., Broadie K. Multifarious Functions of the Fragile X Mental Retardation Protein. Trends Genet 2017; 33(10): 703–714. DOI: 10.1016/j.tig.2017.07.008</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Sánchez-Lafuente C.L., Kalynchuk L.E., Caruncho H.J., Ausió J. The Role of MeCP2 in Regulating Synaptic Plasticity in the Context of Stress and Depression. Cells 2022; 11(4): 748. DOI: 10.3390/cells11040748</mixed-citation><mixed-citation xml:lang="en">Sánchez-Lafuente C.L., Kalynchuk L.E., Caruncho H.J., Ausió J. The Role of MeCP2 in Regulating Synaptic Plasticity in the Context of Stress and Depression. Cells 2022; 11(4): 748. DOI: 10.3390/cells11040748</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Greer P.L., Hanayama R., Bloodgood B.L., Mardinly A.R., Lipton D.M., Flavell S.W. et al. The Angelman Syndrome-associated ubiquitin ligase Ube3A regulates synapse development by ubiquitinating Arc. Cell 2010; 140(5): 704–716. DOI: 10.1016/j.cell.2010.01.026</mixed-citation><mixed-citation xml:lang="en">Greer P.L., Hanayama R., Bloodgood B.L., Mardinly A.R., Lipton D.M., Flavell S.W. et al. The Angelman Syndrome-associated ubiquitin ligase Ube3A regulates synapse development by ubiquitinating Arc. Cell 2010; 140(5): 704–716. DOI: 10.1016/j.cell.2010.01.026</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Chen M., Sun Y., Qian Y., Chen N., Li H., Wang L., Dong M. Case report: FOXP1 syndrome caused by a de novo splicing variant (c.1652+5 G&gt;A) of the FOXP1 gene. Front Genet 2022; 13: 926070. DOI: 10.3389/fgene.2022.926070</mixed-citation><mixed-citation xml:lang="en">Chen M., Sun Y., Qian Y., Chen N., Li H., Wang L., Dong M. Case report: FOXP1 syndrome caused by a de novo splicing variant (c.1652+5 G&gt;A) of the FOXP1 gene. Front Genet 2022; 13: 926070. DOI: 10.3389/fgene.2022.926070</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X., Wang M., Zhang Q., Hou Y., Huang X., Li S., Wu J. Stress response genes associated with attention deficit hyperactivity disorder: A case-control study in Chinese children. Behav Brain Res 2019; 363: 126–134. DOI: 10.1016/j.bbr.2019.01.051</mixed-citation><mixed-citation xml:lang="en">Chen X., Wang M., Zhang Q., Hou Y., Huang X., Li S., Wu J. Stress response genes associated with attention deficit hyperactivity disorder: A case-control study in Chinese children. Behav Brain Res 2019; 363: 126–134. DOI: 10.1016/j.bbr.2019.01.051</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Wu S., Jia M., Ruan Y., Liu J., Guo Y., Shuang M. et al. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol Psychiatry 2005; 58: 74–77. DOI: 10.1016/j.biopsych.2005.03.013</mixed-citation><mixed-citation xml:lang="en">Wu S., Jia M., Ruan Y., Liu J., Guo Y., Shuang M. et al. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol Psychiatry 2005; 58: 74–77. DOI: 10.1016/j.biopsych.2005.03.013</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Kawamura Y., Shimada T., Otowa T., Koishi S., Sugiyama T. et al. Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. J Hum Genet 2010; 55: 137–141. DOI: 10.1038/jhg.2009.140</mixed-citation><mixed-citation xml:lang="en">Liu X., Kawamura Y., Shimada T., Otowa T., Koishi S., Sugiyama T. et al. Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. J Hum Genet 2010; 55: 137–141. DOI: 10.1038/jhg.2009.140</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Lerer E., Levi S., Salomon S., Darvasi A., Yirmiya N., Ebstein R.P. Association between the oxytocin receptor (OXTR) gene and autism: Relationship to Vineland Adaptive Behavior Scales and cognition. Mol Psychiatry 2008; 13: 980–988. DOI: 10.1038/sj.mp.4002087</mixed-citation><mixed-citation xml:lang="en">Lerer E., Levi S., Salomon S., Darvasi A., Yirmiya N., Ebstein R.P. Association between the oxytocin receptor (OXTR) gene and autism: Relationship to Vineland Adaptive Behavior Scales and cognition. Mol Psychiatry 2008; 13: 980–988. DOI: 10.1038/sj.mp.4002087</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">LoParo D., Waldman I.D. The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: A meta-analysis. Mol Psychiatry 2015; 20: 640–646. DOI: 10.1038/mp.2014.77</mixed-citation><mixed-citation xml:lang="en">LoParo D., Waldman I.D. The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: A meta-analysis. Mol Psychiatry 2015; 20: 640–646. DOI: 10.1038/mp.2014.77</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Ocakoğlu F.T., Köse S., Özbaran B., Onay H. The oxytocin receptor gene polymorphism -rs237902- is associated with the severity of autism spectrum disorder: A pilot study. Asian J Psychiatr 2018; 31: 142–149. DOI: 10.1016/j.ajp.2018.01.002</mixed-citation><mixed-citation xml:lang="en">Ocakoğlu F.T., Köse S., Özbaran B., Onay H. The oxytocin receptor gene polymorphism -rs237902- is associated with the severity of autism spectrum disorder: A pilot study. Asian J Psychiatr 2018; 31: 142–149. DOI: 10.1016/j.ajp.2018.01.002</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Yoo H.J., Yang S.Y., Cho I.H., Park M., Kim S.A. Polymorphisms of BDNF Gene and Autism Spectrum Disorders: Family Based Association Study with Korean Trios. Psychiatry Investig 2014; 11(3): 319–324. DOI: 10.4306/pi.2014.11.3.319</mixed-citation><mixed-citation xml:lang="en">Yoo H.J., Yang S.Y., Cho I.H., Park M., Kim S.A. Polymorphisms of BDNF Gene and Autism Spectrum Disorders: Family Based Association Study with Korean Trios. Psychiatry Investig 2014; 11(3): 319–324. DOI: 10.4306/pi.2014.11.3.319</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Li D., Zhang L., Bai T., Huang W., Ji G-J., Yang T. et al. Common variants of the autism-associated CNTNAP2 gene contribute to the modulatory effect of social function mediated by temporal cortex. Behav Brain Res 2021; 409:113319. DOI: 10.1016/j.bbr.2021.113319</mixed-citation><mixed-citation xml:lang="en">Li D., Zhang L., Bai T., Huang W., Ji G-J., Yang T. et al. Common variants of the autism-associated CNTNAP2 gene contribute to the modulatory effect of social function mediated by temporal cortex. Behav Brain Res 2021; 409:113319. DOI: 10.1016/j.bbr.2021.113319</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Wen Z., Cheng T-L., Li G-Z., Sun S-B., Yu S-Y., Zhang Y. et al. Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation. Mol Autism 2017; 8: 43. DOI: 10.1186/s13229–017–0157–5</mixed-citation><mixed-citation xml:lang="en">Wen Z., Cheng T-L., Li G-Z., Sun S-B., Yu S-Y., Zhang Y. et al. Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation. Mol Autism 2017; 8: 43. DOI: 10.1186/s13229–017–0157–5</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Xing L., Simon J.M., Ptacek T.S., Yi J.J., Loo L., Mao H. et al. Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice. Cell Rep 2023; 42(7): 112706. DOI: 10.1016/j.celrep.2023.112706</mixed-citation><mixed-citation xml:lang="en">Xing L., Simon J.M., Ptacek T.S., Yi J.J., Loo L., Mao H. et al. Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice. Cell Rep 2023; 42(7): 112706. DOI: 10.1016/j.celrep.2023.112706</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Moore L., Le T., Fan G. DNA Methylation and Its Basic Function. Neuropsychopharmacol 2013; 38: 23–38. DOI: 10.1038/npp.2012.112</mixed-citation><mixed-citation xml:lang="en">Moore L., Le T., Fan G. DNA Methylation and Its Basic Function. Neuropsychopharmacol 2013; 38: 23–38. DOI: 10.1038/npp.2012.112</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
